These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8345566)

  • 21. Disposition of antipyrine in patients with extensive metastatic liver disease.
    Robertz-Vaupel GM; Lindecken KD; Edeki T; Funke C; Belwon S; Dengler HJ
    Eur J Clin Pharmacol; 1992; 42(5):465-9. PubMed ID: 1606991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosis.
    Teunissen MW; Spoelstra P; Koch CW; Weeda B; van Duyn W; Janssens AR; Breimer DD
    Br J Clin Pharmacol; 1984 Nov; 18(5):707-15. PubMed ID: 6508980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of short-term water deprivation on antipyrine disposition in calves.
    Janus K; Muszczynski Z; Suszycka J
    Res Vet Sci; 1997; 63(1):1-3. PubMed ID: 9368948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of age on antipyrine pharmacokinetics and metabolite formation in rats.
    van Bezooijen CF; van Oorschot RM
    J Pharmacol Exp Ther; 1989 Nov; 251(2):683-6. PubMed ID: 2810117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The regulation of oxidative drug metabolism by growth hormone in the dwarf goat: differences from and similarities to the mechanisms in rats.
    Witkamp RF; Nijmeijer SM; Van Duin CT; Noordhoek J; Van Miert AS
    J Endocrinol; 1993 Feb; 136(2):313-7. PubMed ID: 8459197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence of a subclinical fascioliasis on antipyrine clearance and metabolite excretion in sheep.
    Tufenkji AE; Alvinerie M; Pineau T; Boulard C; Galtier P
    Xenobiotica; 1988 Apr; 18(4):357-64. PubMed ID: 3400265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pharmacokinetics of mefloquine in man: lack of effect of mefloquine on antipyrine metabolism.
    Rivière JH; Back DJ; Breckenridge AM; Howells RE
    Br J Clin Pharmacol; 1985 Nov; 20(5):469-74. PubMed ID: 3878153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of liver damage on antipyrine metabolite formation in rats.
    Tanaka E; Etoh H; Ishikawa A; Nakano M; Misawa S
    Xenobiotica; 1991 May; 21(5):663-7. PubMed ID: 1949899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antipyrine clearance and metabolite excretion in patients with chronic hepatitis C.
    Ali HA; el-Yazigi A; Sieck JO; Ali MA; Raines DA; Saour J; Ernst P; Khan B; Døssing M
    J Hepatol; 1995 Jan; 22(1):17-21. PubMed ID: 7751582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of sex and oral contraceptive steroids on antipyrine metabolite formation.
    Teunissen MW; Srivastava AK; Breimer DD
    Clin Pharmacol Ther; 1982 Aug; 32(2):240-6. PubMed ID: 7094512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of verapamil on antipyrine pharmacokinetics and metabolism in man.
    Bach D; Blevins R; Kerner N; Rubenfire M; Edwards DJ
    Br J Clin Pharmacol; 1986 Jun; 21(6):655-9. PubMed ID: 3741715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of dietary restriction on the metabolism of theophylline and antipyrine in the ageing female BN/BiRij rat.
    Groen K; Breimer DD; Brouwer A; Schijff G; Jansen EJ; van Bezooijen CF
    J Pharmacol Exp Ther; 1995 Jul; 274(1):143-7. PubMed ID: 7616391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of antipyrine and metabolites in plasma of a patient with mild renal failure.
    Lanchote VL; Ping WC; Santos SR
    Ther Drug Monit; 1997 Dec; 19(6):705-10. PubMed ID: 9421115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of hexobarbital and antipyrine metabolism by rifampicin treatment in the pig.
    van den Broek JM; Teunissen MW; Breimer DD
    Drug Metab Dispos; 1981; 9(6):541-4. PubMed ID: 6120813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of diltiazem on hepatic drug oxidation assessed by antipyrine and trimethadione.
    Ohashi K; Sakamoto K; Sudo T; Tateishi T; Harada K; Fujimura A; Ebihara A; Tanaka E
    J Clin Pharmacol; 1991 Dec; 31(12):1132-6. PubMed ID: 1761736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antipyrine metabolism during hepatic regeneration in the rat.
    Poulsen HE; Pilsgaard H
    Liver; 1985 Aug; 5(4):196-9. PubMed ID: 4058271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elimination studies of antipyrine and its metabolites in healthy Saudi Arabians.
    Ali HA; el-Yazigi A; Sieck JO; Døssing M; Saour J; Raines DA; Ernst P
    Hum Exp Toxicol; 1994 Oct; 13(10):658-62. PubMed ID: 7826682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative aspects and sex differentiation of plasma sulfamethazine elimination and metabolite formation in rats, rabbits, dwarf goats, and cattle.
    Witkamp RF; Yun HI; van't Klooster GA; van Mosel JF; van Mosel M; Ensink JM; Noordhoek J; van Miert AS
    Am J Vet Res; 1992 Oct; 53(10):1830-5. PubMed ID: 1456529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Automated high-performance liquid chromatographic determination of antipyrine and its main metabolites in plasma, saliva and urine, including 4,4'-dihydroxyantipyrine.
    Teunissen MW; Meerburg-van der Torren JE; Vermeulen NP; Breimer DD
    J Chromatogr; 1983 Dec; 278(2):367-78. PubMed ID: 6668316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antipyrine metabolism in patients with disseminated testicular cancer and the influence of cytostatic treatment.
    Teunissen MW; Willemse PH; Sleijfer DT; Sluiter WJ; Breimer DD
    Cancer Chemother Pharmacol; 1984; 13(3):181-5. PubMed ID: 6207949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.